MedPath
HSA Approval

PMS-SULFASALAZINE E.C.TABLET 500 mg

SIN06512P

PMS-SULFASALAZINE E.C.TABLET 500 mg

PMS-SULFASALAZINE E.C.TABLET 500 mg

August 19, 1991

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

A07EC01

sulfasalazine

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Dragenopharm Aptheker Pushl Gmbh & Co

Active Ingredients

SULFASALAZINE

500 mg

Sulfasalazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PMS-SULFASALAZINE E.C.TABLET 500 mg - HSA Approval | MedPath